Corey Speers

4.3k total citations
92 papers, 2.0k citations indexed

About

Corey Speers is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Corey Speers has authored 92 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cancer Research, 40 papers in Oncology and 31 papers in Molecular Biology. Recurrent topics in Corey Speers's work include Breast Cancer Treatment Studies (30 papers), Prostate Cancer Treatment and Research (15 papers) and Cancer Genomics and Diagnostics (14 papers). Corey Speers is often cited by papers focused on Breast Cancer Treatment Studies (30 papers), Prostate Cancer Treatment and Research (15 papers) and Cancer Genomics and Diagnostics (14 papers). Corey Speers collaborates with scholars based in United States, Canada and Sweden. Corey Speers's co-authors include Lori J. Pierce, Felix Y. Feng, Daniel E. Spratt, Kari Wilder-Romans, Meilan Liu, Arul M. Chinnaiyan, Powel H. Brown, Joseph R. Osborne, Levi Waldron and Prasanna Alluri and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Corey Speers

82 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Corey Speers United States 23 818 809 800 622 294 92 2.0k
Cordula Petersen Germany 26 870 1.1× 493 0.6× 1.0k 1.3× 435 0.7× 240 0.8× 60 2.0k
Susan Cleator United Kingdom 20 996 1.2× 811 1.0× 714 0.9× 362 0.6× 182 0.6× 46 2.0k
Per Malmström Sweden 26 1.3k 1.6× 1.1k 1.4× 1.0k 1.3× 515 0.8× 386 1.3× 61 2.6k
Mohamed E. Abazeed United States 20 355 0.4× 449 0.6× 565 0.7× 474 0.8× 109 0.4× 67 1.6k
G. N. Hortobágyi United States 23 1.7k 2.1× 962 1.2× 573 0.7× 543 0.9× 176 0.6× 106 2.7k
Florence Lerebours France 29 1.4k 1.7× 1.2k 1.5× 915 1.1× 692 1.1× 248 0.8× 97 2.6k
Theodoros Foukakis Sweden 33 2.1k 2.6× 1.5k 1.8× 1.4k 1.8× 726 1.2× 293 1.0× 135 4.1k
Virginia K. Langmuir United States 18 1.1k 1.3× 776 1.0× 920 1.1× 446 0.7× 77 0.3× 45 2.3k
David Chen United States 25 1.4k 1.7× 877 1.1× 1.4k 1.8× 1.5k 2.4× 560 1.9× 75 3.6k
Guang‐Yu Liu China 25 1.0k 1.3× 1.1k 1.4× 492 0.6× 348 0.6× 214 0.7× 108 2.1k

Countries citing papers authored by Corey Speers

Since Specialization
Citations

This map shows the geographic impact of Corey Speers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corey Speers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corey Speers more than expected).

Fields of papers citing papers by Corey Speers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corey Speers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corey Speers. The network helps show where Corey Speers may publish in the future.

Co-authorship network of co-authors of Corey Speers

This figure shows the co-authorship network connecting the top 25 collaborators of Corey Speers. A scholar is included among the top collaborators of Corey Speers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corey Speers. Corey Speers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winer, Eric P., Laura A. Levit, Ethan Basch, et al.. (2025). Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers. Journal of Clinical Oncology. 43(17). 2017–2023. 2 indexed citations
2.
McClelland, Shearwood, et al.. (2025). Quantification and Qualification of Breast Cancer Patient Navigation from the Navigator-Assisted Hypofractionation (NAVAH) Phase I Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 123(1). S182–S182. 1 indexed citations
3.
Speers, Corey, et al.. (2024). Present and Future of Immunotherapy for Triple-Negative Breast Cancer. Cancers. 16(19). 3250–3250. 7 indexed citations
4.
Sjöström, Martin, Anthony Fyles, Fei‐Fei Liu, et al.. (2023). Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer. Journal of Clinical Oncology. 41(8). 1533–1540. 21 indexed citations
5.
Jagsi, Reshma, William E. Barlow, Wendy A. Woodward, et al.. (2023). Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial. JAMA Oncology. 9(8). 1083–1083. 6 indexed citations
6.
Speers, Corey, W. Fraser Symmans, William E. Barlow, et al.. (2023). Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial. Journal of Clinical Oncology. 41(10). 1841–1848. 9 indexed citations
7.
Michmerhuizen, Anna R., Rachel Schwartz, Kari Wilder-Romans, et al.. (2022). Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer. British Journal of Cancer. 127(5). 927–936. 4 indexed citations
8.
Chandler, Benjamin C., Anna R. Michmerhuizen, Kari Wilder-Romans, et al.. (2022). Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression. Cancer Research Communications. 2(7). 679–693. 7 indexed citations
9.
Michmerhuizen, Anna R., Rachel Schwartz, Kari Wilder-Romans, et al.. (2022). Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models. npj Breast Cancer. 8(1). 31–31. 14 indexed citations
10.
Michmerhuizen, Anna R., Kari Wilder-Romans, Benjamin C. Chandler, et al.. (2021). RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes. JCI Insight. 7(3). 21 indexed citations
11.
Puttonen, Henri, Martin Sjöström, Erik Holmberg, et al.. (2020). Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial. Clinical Cancer Research. 27(3). 749–758. 17 indexed citations
12.
Chandler, Benjamin C., Anna R. Michmerhuizen, Kari Wilder-Romans, et al.. (2020). Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers. Clinical Cancer Research. 26(24). 6568–6580. 35 indexed citations
13.
Michmerhuizen, Anna R., Daniel E. Spratt, Lori J. Pierce, & Corey Speers. (2020). ARe we there yet? Understanding androgen receptor signaling in breast cancer. npj Breast Cancer. 6(1). 47–47. 76 indexed citations
14.
Kregel, Steven, Rohit Malik, Irfan A. Asangani, et al.. (2019). Functional and Mechanistic Interrogation of BET Bromodomain Degraders for the Treatment of Metastatic Castration-resistant Prostate Cancer. Clinical Cancer Research. 25(13). 4038–4048. 26 indexed citations
15.
Michmerhuizen, Anna R., Benjamin C. Chandler, Kari Wilder-Romans, et al.. (2019). PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation. Molecular Cancer Therapeutics. 18(11). 2063–2073. 41 indexed citations
16.
Sjöström, Martin, S. Laura Chang, Nick Fishbane, et al.. (2019). Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic Therapy. Clinical Cancer Research. 26(1). 171–182. 12 indexed citations
17.
Wahl, Daniel, Joseph Dresser, Kari Wilder-Romans, et al.. (2016). Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis. Cancer Research. 77(4). 960–970. 67 indexed citations
18.
Speers, Corey, Shuang Zhao, Meilan Liu, et al.. (2015). Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer. Clinical Cancer Research. 21(16). 3667–3677. 114 indexed citations
19.
Speers, Corey, Anna Tsimelzon, K. Sexton, et al.. (2009). Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor–Negative Breast Cancer. Clinical Cancer Research. 15(20). 6327–6340. 77 indexed citations
20.
Chen, Lü, Julie Ann Mayer, Tibor I. Krisko, et al.. (2009). Inhibition of the p38 Kinase Suppresses the Proliferation of Human ER-Negative Breast Cancer Cells. Cancer Research. 69(23). 8853–8861. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cordula Petersen Breakdown of academic impact, for papers by Susan Cleator Breakdown of academic impact, for papers by Per Malmström Breakdown of academic impact, for papers by Mohamed E. Abazeed Breakdown of academic impact, for papers by G. N. Hortobágyi Breakdown of academic impact, for papers by Florence Lerebours Breakdown of academic impact, for papers by Theodoros Foukakis Breakdown of academic impact, for papers by Virginia K. Langmuir Breakdown of academic impact, for papers by David Chen Breakdown of academic impact, for papers by Guang‐Yu Liu
Rankless by CCL
2026